Aeromedical evacuation using an aircraft transit isolator of a patient with Lassa fever

Area of Science:

• Medical evacuation protocols
• Infectious disease management
• Aviation safety

Background:

• Lassa fever is a viral hemorrhagic fever endemic to West Africa with a significant mortality rate, particularly among hospitalized patients.
• Human-to-human transmission primarily occurs through direct contact with infected bodily fluids, necessitating stringent isolation during transport.
• Aeromedical evacuation of patients with highly contagious diseases like Lassa fever is rarely reported and requires specialized containment.

Observation:

• A case report details the aeromedical evacuation of a confirmed Lassa fever patient from Sierra Leone to Sweden.
• The transport utilized a dedicated air ambulance equipped with an aircraft transit isolator, a specialized containment device.
• The entire mission, from activation to hospital arrival, was completed within 36 hours, adhering to WHO guidelines.

Findings:

• The successful evacuation demonstrates the feasibility of transporting Lassa fever patients internationally using advanced isolation technology.
• The aircraft transit isolator proved effective in maintaining containment, minimizing risk to the medical and flight crew.
• The 36-hour mission duration met international recommendations for time-sensitive patient transfers.

Implications:

• This case highlights the critical importance of specialized equipment, such as aircraft transit isolators, for managing high-consequence infectious disease evacuations.
• Training for medical and technical crews in the use of isolation equipment and procedures is essential for safe operations.
• Implementing such protocols can improve global health security by enabling rapid transfer of patients for advanced care or research.